apomorphine has been researched along with Huntington Disease in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (41.03) | 18.7374 |
| 1990's | 13 (33.33) | 18.2507 |
| 2000's | 6 (15.38) | 29.6817 |
| 2010's | 4 (10.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Döbrössy, MD; Nikkhah, G; Pauly, MC; Piroth, T; Schackel, S | 1 |
| Boll, MC; Campos-Arroyo, HD; Martínez-Lazcano, JC; Montes, S; Pérez-Neri, I; Pérez-Severiano, F; Ríos, C; Rodríguez-Páez, L; Sánchez-Mendoza, MA | 1 |
| Bertolino, G; de Araujo, JE; Giorgetto, C; Kitabatake, TT; Silva, EC | 1 |
| Armida, M; Calamandrei, G; Pezzola, A; Popoli, P; Potenza, RL; Tartaglione, AM | 1 |
| Büchele, F; Döbrössy, M; Jiang, W; Nikkhah, G; Papazoglou, A | 1 |
| Chu, K; Kang, L; Kim, M; Kim, SU; Lee, K; Lee, ST; Park, JE | 1 |
| Carmichael, ST; Erickson, RI; Kornblum, HI; Oknaian, N; Simonian, S; Tatsukawa, KJ; Visnyei, K | 1 |
| Chen, K; Connor, B; Hughes, SM; Vazey, EM | 1 |
| Chu, K; Chung, H; Hwang, T; Kang, W; Kim, M; Lee, SE; Lee, ST; Park, JE; Song, J | 1 |
| Barone, P; Bonavita, V; De Michele, G; Di Maio, L; Longo, K; Marconi, S; Vitale, C | 1 |
| Caraceni, TA; Giovannini, P; Girotti, F; Parati, EA; Pederzoli, M | 1 |
| Meltzer, HY | 1 |
| Chase, TN; Denaro, A; Durso, R; Ruggeri, S; Tamminga, CA | 1 |
| Bernardi, F; Corsini, GU; Gessa, GL; Marrosu, F | 1 |
| Borlongan, CV; Cahill, DW; Randall, TS; Sanberg, PR | 1 |
| Beal, MF; Brouillet, E; Dolan, R; Ferrante, RJ; Guyot, MC; Hantraye, P; Palfi, S; Peschanski, M | 1 |
| Albanese, A; Bentivoglio, AR; Carretta, D; Cassetta, E; Tonali, P | 1 |
| Conrad, JA; Kondoh, T; Low, WC; Pundt, LL | 1 |
| Albanese, A; Colosimo, C; Merello, M | 1 |
| Brouillet, E; Chibois, A; Condé, F; Dautry, C; Hantraye, P; Mittoux, V; Palfi, S; Peschanski, M; Riche, D | 1 |
| Chopin, P; Colpaert, F; Marien, M; Martel, J | 1 |
| Itakura, T; Nakai, K; Nakao, N; Ogura, M | 1 |
| Donatelli, L | 1 |
| Fibiger, HC; Mason, ST; Sanberg, PR | 1 |
| Fibiger, HC; Mason, ST | 1 |
| Sparber, SB; Tolosa, ES | 2 |
| Tolosa, ES | 1 |
| Cianchetti, C; Corsini, GU; Gessa, G; Mangoni, A; Masala, C; Onali, P | 1 |
| Carlson, HE; Goodlett, RE; Hershman, JM; Levy, CL; Sowers, JR; Tourtellotte, WW | 1 |
| Caraceni, T; Cocchi, D; Müller, EE; Panerai, AE; Parati, EA | 1 |
| Fibiger, HC; Lehmann, J; Sanberg, PR | 1 |
| Brownell, AL; Brownell, GL; Davenport, PD; Elmaleh, DR; Hantraye, P; Isacson, O; Madras, BK; Maziere, M; Riche, D; Schumacher, JM | 1 |
| Hantraye, P; Isacson, O; Maziere, M; Riche, D | 2 |
| Burton, S; Daya, S; Potgieter, B | 1 |
| Hantraye, P; Isacson, O; Maziere, M; Riche, D; Sofroniew, MV | 1 |
| Fernandez Pardal, MM; Micheli, F | 1 |
| Holland, OB; Kennedy, B; Lake, CR; Murphy, D; Ziegler, MG | 1 |
2 review(s) available for apomorphine and Huntington Disease
| Article | Year |
|---|---|
Dopamine autoreceptor stimulation: clinical significance.
Topics: Apomorphine; Dopamine; Haloperidol; Humans; Huntington Disease; Mental Disorders; Neurons; Parkinson Disease; Piribedil; Receptors, Dopamine; Relaxation; Schizophrenia; Sleep; Tourette Syndrome | 1982 |
Clinical usefulness of apomorphine in movement disorders.
Topics: Antiparkinson Agents; Apomorphine; Dopamine Agonists; Dystonia; Humans; Huntington Disease; Movement Disorders; Neuroleptic Malignant Syndrome; Parkinson Disease | 1994 |
6 trial(s) available for apomorphine and Huntington Disease
| Article | Year |
|---|---|
Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial.
Topics: Adult; Antiparkinson Agents; Apomorphine; Cross-Over Studies; Depression; Double-Blind Method; Female; Humans; Huntington Disease; Infusions, Intravenous; Male; Middle Aged; Mood Disorders; Movement; Movement Disorders; Pilot Projects; Psychiatric Status Rating Scales | 2007 |
Effects of DA agonist in Huntington disease hyperkinesia.
Topics: Adult; Apomorphine; Bromocriptine; Clinical Trials as Topic; Cyproheptadine; Diazepam; Female; Growth Hormone; Humans; Huntington Disease; Lisuride; Male; Middle Aged | 1980 |
Acute challenge with apomorphine in Huntington's disease: a double-blind study.
Topics: Adult; Apomorphine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Huntington Disease; Male; Middle Aged | 1995 |
Studies on the anti-dyskinesia effect of apomorphine in man.
Topics: Administration, Oral; Adult; Aged; Apomorphine; Clinical Trials as Topic; Drug Evaluation; Female; Haloperidol; Humans; Huntington Disease; Injections, Intravenous; Levodopa; Male; Middle Aged; Movement Disorders | 1976 |
Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor.
Topics: Adult; Apomorphine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Haloperidol; Humans; Huntington Disease; Male; Middle Aged; Premedication; Receptors, Dopamine; Sulpiride | 1978 |
Responses to lisuride in Meige's disease and chorea.
Topics: Aged; Apomorphine; Basal Ganglia Diseases; Clinical Trials as Topic; Ergolines; Female; Humans; Huntington Disease; Lisuride; Male; Meige Syndrome; Middle Aged | 1986 |
31 other study(ies) available for apomorphine and Huntington Disease
| Article | Year |
|---|---|
Donor age dependent graft development and recovery in a rat model of Huntington's disease: histological and behavioral analysis.
Topics: Age Factors; Animals; Apomorphine; Brain Tissue Transplantation; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Female; Fetal Tissue Transplantation; Globus Pallidus; Huntington Disease; Motor Activity; Neurons; Quinolinic Acid; Rats, Sprague-Dawley; Recovery of Function | 2013 |
Sub-chronic copper pretreatment reduces oxidative damage in an experimental Huntington's disease model.
Topics: Animals; Apomorphine; Copper; Disease Models, Animal; gamma-Aminobutyric Acid; Huntington Disease; Lipid Peroxidation; Male; Oxidative Stress; Quinolinic Acid; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase | 2014 |
Behavioural profile of Wistar rats with unilateral striatal lesion by quinolinic acid (animal model of Huntington disease) post-injection of apomorphine and exposure to static magnetic field.
Topics: Analysis of Variance; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Functional Laterality; Huntington Disease; Magnetic Fields; Male; Motor Activity; Neurons; Quinolinic Acid; Rats; Rats, Wistar; Statistics as Topic | 2015 |
Aberrant self-grooming as early marker of motor dysfunction in a rat model of Huntington's disease.
Topics: Animals; Apomorphine; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Grooming; Huntington Disease; Male; Quinolinic Acid; Rats; Rats, Sprague-Dawley | 2016 |
Ketamine anaesthesia interferes with the quinolinic acid-induced lesion in a rat model of Huntington's disease.
Topics: Anesthetics, Inhalation; Animals; Antiparkinson Agents; Apomorphine; Brain; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Female; Huntington Disease; Isoflurane; Ketamine; Neurons; Neurotoxins; Quinolinic Acid; Rats; Rats, Sprague-Dawley | 2009 |
Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model.
Topics: Animals; Apomorphine; Behavior, Animal; Cell Count; Cells, Cultured; Corpus Striatum; Disease Models, Animal; DNA-Binding Proteins; Dopamine and cAMP-Regulated Phosphoprotein 32; Drosophila Proteins; Endogenous Retroviruses; Functional Laterality; Galactosides; gamma-Aminobutyric Acid; Glial Fibrillary Acidic Protein; Humans; Huntington Disease; Immunohistochemistry; Indoles; Infusions, Intravenous; Male; Motor Activity; Nerve Tissue Proteins; Neurons; Parvalbumins; Phosphoproteins; Phosphopyruvate Hydratase; Quinolinic Acid; Random Allocation; Rats; Rats, Sprague-Dawley; Recovery of Function; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rotarod Performance Test; Stem Cell Transplantation; Stem Cells; Time Factors | 2005 |
Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion.
Topics: Analysis of Variance; Animals; Apomorphine; Autoradiography; Behavior, Animal; Cell Count; Corpus Striatum; Disease Models, Animal; Embryo, Mammalian; Functional Laterality; Huntington Disease; Immunohistochemistry; Male; Motor Activity; Neurons; Positron-Emission Tomography; Quinolinic Acid; Radiography; Rats; Rats, Sprague-Dawley; Recovery of Function; Rotarod Performance Test; Stem Cell Transplantation; Stem Cells | 2006 |
Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease.
Topics: Analysis of Variance; Animals; Apomorphine; Brain Tissue Transplantation; Bromodeoxyuridine; Cell Count; Cell Differentiation; Disease Models, Animal; Dopamine Agonists; Huntington Disease; Immunohistochemistry; Male; Motor Activity; Neostriatum; Nerve Tissue Proteins; Neurons; Quinolinic Acid; Rats; Rats, Wistar; Stem Cell Transplantation; Time Factors; Transcription Factors; Tyrosine 3-Monooxygenase | 2006 |
Human embryonic stem cell-derived neural precursor transplants attenuate apomorphine-induced rotational behavior in rats with unilateral quinolinic acid lesions.
Topics: Animals; Apomorphine; Cell Differentiation; Cell Line; Dopamine Agonists; Embryonic Stem Cells; Huntington Disease; Immunohistochemistry; Male; Microinjections; Neostriatum; Neurons; Neurotoxicity Syndromes; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Stromal Cells | 2007 |
Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease.
Topics: Adult; Apomorphine; Arecoline; Dopamine; Female; gamma-Aminobutyric Acid; Growth Hormone; Humans; Huntington Disease; Male; Muscimol; Oxazoles; Prolactin | 1983 |
Neuropsychiatric implications of drugs acting on dopamine receptors: the effect of apomorphine.
Topics: Animals; Apomorphine; Bipolar Disorder; Blood-Brain Barrier; Electroencephalography; Humans; Huntington Disease; Motor Activity; Parkinson Disease; Rats; Receptors, Dopamine; Schizophrenia; Sleep | 1980 |
Asymmetrical motor behavior in rats with unilateral striatal excitotoxic lesions as revealed by the elevated body swing test.
Topics: Animals; Apomorphine; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Functional Laterality; Huntington Disease; Male; Motor Activity; Neurotoxins; Nitro Compounds; Propionates; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Time Factors | 1995 |
Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease.
Topics: Animals; Apomorphine; Behavior, Animal; Brain; Cognition; Huntington Disease; Movement; Neurotoxins; Nitro Compounds; Papio; Propionates; Time Factors | 1996 |
Transplantation of human fetal striatum into a rodent model of Huntington's disease ameliorates locomotor deficits.
Topics: Acetylcholinesterase; Animals; Antiparkinson Agents; Apomorphine; Brain Tissue Transplantation; Coloring Agents; Disease Models, Animal; Fetal Tissue Transplantation; Histocytochemistry; Humans; Huntington Disease; Locomotion; Male; NADPH Dehydrogenase; Neostriatum; Phenothiazines; Rats; Rats, Sprague-Dawley; Rotation | 1996 |
Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease.
Topics: Animals; Apomorphine; Brain Tissue Transplantation; Cognition; Corpus Striatum; Fetal Tissue Transplantation; Huntington Disease; Macaca fascicularis; Magnetic Resonance Imaging; Motor Activity; Nitro Compounds; Propionates; Transplantation, Homologous | 1998 |
Neuroprotective effects of the alpha2-adrenoceptor antagonists, (+)-efaroxan and (+/-)-idazoxan, against quinolinic acid-induced lesions of the rat striatum.
Topics: Adrenergic alpha-Antagonists; Animals; Apomorphine; Behavior, Animal; Benzofurans; Choline O-Acetyltransferase; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Enzyme Activation; Huntington Disease; Idazoxan; Imidazoles; Male; Nerve Degeneration; Neuroprotective Agents; Neurotoxins; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2 | 1998 |
Embryonic striatal grafts restore neuronal activity of the globus pallidus in a rodent model of Huntington's disease.
Topics: Action Potentials; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Brain Tissue Transplantation; Corpus Striatum; Disease Models, Animal; Electron Transport Complex IV; Electrophysiology; Fetal Tissue Transplantation; Globus Pallidus; Huntington Disease; Male; Neurons; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Rotation | 1999 |
[The Cools and van Rossum theory and the pharmacology of Huntington's chorea].
Topics: Animals; Apomorphine; Brain; Cats; Dopamine; Dopamine beta-Hydroxylase; Drug Therapy, Combination; Ergonovine; Huntington Disease; Levodopa; Rats; Sulpiride; Tyrosine 3-Monooxygenase | 1977 |
Kainic acid lesions of the striatum dissociate amphetamine and apomorphine stereotypy: similarities to Huntingdon's chorea.
Topics: Animals; Apomorphine; Behavior; Choline O-Acetyltransferase; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Glutamate Decarboxylase; Humans; Huntington Disease; Kainic Acid; Male; Nucleus Accumbens; Pyrrolidines; Rats; Stereotyped Behavior; Tyrosine 3-Monooxygenase | 1978 |
Kainic acid lesions of the striatum: behavioural sequalae similar to Huntington's chorea.
Topics: Animals; Apomorphine; Cerebral Cortex; Choline O-Acetyltransferase; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Glutamate Decarboxylase; Habituation, Psychophysiologic; Humans; Huntington Disease; Kainic Acid; Male; Motor Activity; Neurons; Nucleus Accumbens; Pyrrolidines; Rats; Stereotyped Behavior; Tyrosine 3-Monooxygenase | 1978 |
Huntington chorea.
Topics: Apomorphine; Bromocriptine; Humans; Huntington Disease | 1977 |
Growth hormone and prolactin secretion in Huntington's disease.
Topics: Adult; Aged; Apomorphine; Chlorpromazine; Female; Growth Hormone; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors | 1979 |
Growth hormone hyperresponsiveness to dopaminergic stimulation in Huntington's chorea.
Topics: Adult; Apomorphine; Bromocriptine; Female; Growth Hormone; Humans; Huntington Disease; Hypothalamo-Hypophyseal System; Levodopa; Male; Middle Aged; Receptors, Dopamine | 1979 |
Sedative effects of apomorphine in an animal model of Huntington's disease.
Topics: Animals; Apomorphine; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Humans; Huntington Disease; Kainic Acid; Male; Motor Activity; Rats; Receptors, Dopamine; Stereotyped Behavior | 1979 |
A primate model of Huntington's disease: functional neural transplantation and CT-guided stereotactic procedures.
Topics: Animals; Apomorphine; Brain Tissue Transplantation; Carbon Radioisotopes; Caudate Nucleus; Cocaine; Deoxyglucose; Female; Fetal Tissue Transplantation; Fluorodeoxyglucose F18; Glucose; Graft Survival; Huntington Disease; Ibotenic Acid; Male; Motor Activity; Neurotoxins; Papio; Putamen; Quinolinic Acid; Rats; Stereotaxic Techniques; Tomography, Emission-Computed; Tomography, X-Ray Computed; Transplantation, Heterologous | 1992 |
Intrastriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington disease.
Topics: Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Fetus; Huntington Disease; Immunosuppression Therapy; Papio; Regression Analysis; Transplantation, Heterologous | 1992 |
Melatonin modulates apomorphine-induced rotational behaviour.
Topics: Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Huntington Disease; Hydroxydopamines; Male; Melatonin; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Quinolinic Acid; Quinolinic Acids; Rats; Rats, Inbred Strains | 1991 |
A primate model of Huntington's disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon.
Topics: Animals; Apomorphine; Behavior, Animal; Brain Diseases; Caudate Nucleus; Disease Models, Animal; Dystonia; Female; Huntington Disease; Ibotenic Acid; Male; Motor Activity; Movement; Papio; Putamen | 1990 |
Apomorphine-induced dyskinesias after excitotoxic caudate-putamen lesions and the effects of neural transplantation in non-human primates.
Topics: Animals; Apomorphine; Brain Tissue Transplantation; Caudate Nucleus; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Fetal Tissue Transplantation; Huntington Disease; Ibotenic Acid; Male; Papio; Putamen; Rats; Species Specificity; Transplantation, Heterologous | 1990 |
The effects of dopamine agonists on human cardiovascular and sympathetic nervous systems.
Topics: Adult; Aged; Apomorphine; Blood Pressure; Bromocriptine; Cardiovascular System; Catecholamines; Dopamine; Dopamine beta-Hydroxylase; Female; Heart Rate; Hemodynamics; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Parkinson Disease; Pulse; Sympathetic Nervous System | 1985 |
Apomorphine in Huntington's chorea: clinical observations and theoretical considerations.
Topics: Adult; Aged; Apomorphine; Dopamine; Female; Humans; Huntington Disease; Hyperkinesis; Male; Middle Aged; Receptors, Dopamine | 1974 |